- P-ISSN 1225-0163
- E-ISSN 2288-8985
Currently, the potentiometric titration and the high pressure liquid chromatography (HPLC) method were utilized in Korean Pharmacopoeia XII (KP XII) as well as other pharmacopoeias (USP, EP, BP) for determination of loperamide hydrochloride in raw materials and capsules, respectively. The research objective is to overcome the remaining drawbacks from current methods such as solubility of mobile phase (KP XII), less scientific approach (USP 43) or using paired-ion chromatography reagent which shows some limitations (BP2017 and other formulation monographs). The proposed method was optimized by Design of Experiment (DoE) tool to obtain the satisfied method for determination of loperamide hydrochloride. The optimal condition was performed on the common C18 column (150 mm × 4.6 mm; 5 μm) using isocratic elution with the mobile phase containing 40 mM of potassium phosphate monobasic (pH 3.0) and acetonitrile (56:44), at a flow rate of 0.7 mL/min. The optimized method was validated and met the requirements of the International Conference on Harmonization. The developed method was applied to determine loperamide hydrochloride in capsules and can be used to update the current monograph in KP XII.
1. National Library of Medicine, https://pubchem.ncbi.nlm. nih.gov/compound/Loperamide-hydrochloride, Assessed 22 October 2020.
2. FDA assessment, https://www.fda.gov/drugs/postmarketdrug-safety-information-patients-and-providers/loperamidemarketed-imodium-d-information, Assessed 22 October 2020.
3. J. Andreyev, P. Ross, C. Donnellan, E. Lennan, P. Leonard, C. Waters, L. Wedlake, J. Bridgewater, R. Glynne-Jones, W. Allum, I. Chau, R. Wilson and D. Ferry, Lancet Oncol., 15(10), e447-e460 (2014).
4. Ministry of Food and Drug Safety, The Korean Pharmacopoeia, 12th Edition, Republic of Korea (2019).
5. The United States Pharmacopeial Convention, The United States Pharmacopeia, USP 43 NF 38, United States (2020).
6. The Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM), The European Pharmacopoeia, 10th Edition (2020).
7. Medicines & Healthcare Products Regulatory Agency, British Pharmacopoeia, United Kingdom (2017).
8. A. P. Schellinger and P. W. Carr, LCGC North America, 22, 544-548 (2004).
9. M. A. Bezerra, R. E. Santelli, E. P. Oliveira, L. S. Villar and L. A. Escaleira, Talanta, 76(5), 965-977 (2008).
10. L. V. Candioti, M. M. D. Zan, M. S. Cámara and H. C. Goicoechea, Talanta, 124, 123-138 (2014).
11. T. Le, T. Pham, X. Mai, C. Song, S. Woo, C. Jeong, S. Choi, T. D. Phan and K. H. Kim, Analytical Science and Technology, 33(1), 1-10 (2020).
12. T. Pham, X. Mai, T. Le, J. Lee, G. Lee, D. Kim, S. Han and K. H. Kim, Bull. Korean Chem. Soc., 40, 863-871(2019).
13. ICH Guideline. Q2(R1): validation of Analytical Procedures: Text and Methodology Q2(R1) in ICH Harmonised Tripartite Guideline (2005).